Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
ITP
Questions discussed in this category
How do you approach an ITP patient who responds very well to steroids but the response is short-lived?
How would you counsel the patient if he/she wants to continue on steroids?
3 Answers available
How do you approach very treatment-refractory ITP?
Such as the case in which a patient is unresponsive to steroids, IVIG, TPO-agonist, rituximab, splenectomy, and even fostamitinib.
1 Answer available
Based on recent data would you consider adding ATRA to low dose rituximab for steroid refractory ITP?
Wu et al., PMID 34665865
1 Answer available
At what platelet count would you feel comfortable dosing aspirin 81 mg for coronary artery disease in a patient with ITP?
Presuming strong indication for ASA - eg history of NSTEMI
1 Answer available
For treatment of ITP, what would you add to dexamethasone to achieve the fastest recovery in a patient waiting for a procedure?
IVIG, TPO, or other agents?
1 Answer available
Are there any reasons to consider a prolonged course of steroids with taper over a shorter course of pulsed steroids in the treatment of ITP?
For example, do we prefer one regimen over the other in patients with a bleeding history or who have relapsed after a lengthy remission?
1 Answer available
When (if ever) do you check for anti-platelet antibodies for workup of thrombocytopenia?
1 Answer available
How do you approach the treatment of ITP in a pregnant patient who did not respond to prednisone?
Would you consider high-dose dexamethasone (deliberating adverse effects of antenatal steroids) or move to next-line therapies?
1 Answer available
15580
8610
12597
10957
11798
8606
9696
9345
Related Topics
Internal Medicine
Thrombocytopenia
Hematology
Benign Hematology
Pediatric Hematology/Oncology
Medical Oncology
Pediatric Hematology
Neurology
COVID-19
COVID-19 virus